CID 71475839

Vamotinib

Structural Information

Molecular Formula
C29H27F3N6O
SMILES
CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=NN=C5N4C=CC=C5
InChI
InChI=1S/C29H27F3N6O/c1-20-6-7-22(17-21(20)9-11-27-35-34-26-5-3-4-12-38(26)27)28(39)33-24-10-8-23(25(18-24)29(30,31)32)19-37-15-13-36(2)14-16-37/h3-8,10,12,17-18H,13-16,19H2,1-2H3,(H,33,39)
InChIKey
SLIVDYMORZGPLW-UHFFFAOYSA-N
Compound name
4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-[2-([1,2,4]triazolo[4,3-a]pyridin-3-yl)ethynyl]benzamide
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

3
References

240
Patents

532.21985 Da
Monoisotopic Mass

5.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 533.22713 227.3
[M+Na]+ 555.20907 235.2
[M-H]- 531.21257 225.2
[M+NH4]+ 550.25367 226.1
[M+K]+ 571.18301 222.2
[M+H-H2O]+ 515.21711 204.3
[M+HCOO]- 577.21805 229.5
[M+CH3COO]- 591.23370 228.7
[M+Na-2H]- 553.19452 222.6
[M]+ 532.21930 216.1
[M]- 532.22040 216.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe